Planning and Evaluation provides the cancer center with the expertise of cancer scientists and physicians through its External Advisory Board members to advise the center on Its scientific direction, development and foci of scientific programs and shared resources, and its fulfillment of expectations of the National Cancer Institute. In addition, the center avails itself of subject specific expertise through consultations with individual external advisers or experts drawn from particular areas of cancer research and research resources. As part of a modern teaching and research university, the center is also provided feedback from leading faculty at UC Davis in the School of Medicine and other schools and colleges. The center holds planning meetings of its key research personnel, and collaborative conferences to chart new areas of concentration and team science. Finally, using Web-based technologies and database management systems, the center plans utilization of new tools to survey Its members and expand the Information infrastructure available to clinical and laboratory investigators.
Because science is constantly evolving, and in particular, the science underlying cancer research is always developing, a center must undertake external and internal evaluation and strategic planning to assure that its scientific emphases are appropriate in consideration of the state of the areas.
|York, D; Sproul, C D; Chikere, N et al. (2018) Expression and targeting of transcription factor ATF5 in dog gliomas. Vet Comp Oncol 16:102-107|
|Wang, Minan; Yao, Li-Chin; Cheng, Mingshan et al. (2018) Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy. FASEB J 32:1537-1549|
|Wang, Fuli; Zhang, Hongyong; Ma, Ai-Hong et al. (2018) COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin. Mol Cancer Ther 17:474-483|
|Fletcher, Kyle; Klosterman, Steven J; Derevnina, Lida et al. (2018) Comparative genomics of downy mildews reveals potential adaptations to biotrophy. BMC Genomics 19:851|
|Seo, Jai Woong; Tavaré, Richard; Mahakian, Lisa M et al. (2018) CD8+ T-Cell Density Imaging with 64Cu-Labeled Cys-Diabody Informs Immunotherapy Protocols. Clin Cancer Res 24:4976-4987|
|Yuan, Ye; He, Yixuan; Bo, Ruonan et al. (2018) A facile approach to fabricate self-assembled magnetic nanotheranostics for drug delivery and imaging. Nanoscale 10:21634-21639|
|Knight, Jennifer F; Sung, Vanessa Y C; Kuzmin, Elena et al. (2018) KIBRA (WWC1) Is a Metastasis Suppressor Gene Affected by Chromosome 5q Loss in Triple-Negative Breast Cancer. Cell Rep 22:3191-3205|
|Xue, Xiangdong; Huang, Yee; Bo, Ruonan et al. (2018) Trojan Horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment. Nat Commun 9:3653|
|Dou, John; Schmidt, Rebecca J; Benke, Kelly S et al. (2018) Cord blood buffy coat DNA methylation is comparable to whole cord blood methylation. Epigenetics 13:108-116|
|Couto, K M; Moore, P F; Zwingenberger, A L et al. (2018) Clinical characteristics and outcome in dogs with small cell T-cell intestinal lymphoma. Vet Comp Oncol 16:337-343|
Showing the most recent 10 out of 836 publications